Adamax spray 10 mg

Descripción

ADAMAX SPRAY 10mg

Descripción:
ADAMAX is an advanced version of SEMAX, a neuropeptide developed by the Molecular Genetics Institute of the Russian Academy of Sciences. It is recognized as the most potent derivative of Semax. The composition of Adamax consists of an N-acetyl derivative of Semax, which is capped at the C-terminus with an adamantyl component from P21.

Mecanismo de acción:
ADAMAX is known to enhance levels of Brain-Derived Neurotrophic Factor (BDNF) and improve the sensitivity of TrkB receptors within the hippocampus. It effectively increases cognitive capacity in a highly efficient, consistent, and sustainable manner.

Furthermore, ADAMAX is a lipophilic diamine with significant mass, which aids in preventing enzymatic degradation, thus prolonging its effectiveness and preventing temperature-induced degradation.

Beneficios:
ADAMAX contributes to increased stamina, accelerates recovery from intense physical exercise, and stimulates sustained mental activity over time. Research indicates that ADAMAX improves endurance 2-3 times better than other SEMAX analogues, attributed to its unique adamantyl group and enhanced stability of bioactivity after crossing the blood-brain barrier (BBB). Regular, prolonged usage of ADAMAX has shown improvements in cognitive functions.

Dosificación:
ADAMAX is typically administered at a dosage of 10 mg via spray. Specific dosage instructions should be followed based on research purposes or under the guidance of a healthcare professional.

Información importante:
– This product (substance) is not a food or dietary supplement and is not suitable for human consumption.
– Mantener fuera del alcance de los niños.
– Ensure the container is tightly closed.
– Almacenar en un lugar seco, fresco y sombreado; proteger de la humedad.
– Keep the product in its original container.
– Evitar el contacto durante el embarazo y la lactancia.
– If any discomfort or adverse effects occur from contact, seek medical advice immediately.

Nota:
ADAMAX should be treated as an experimental compound and not be purchased based solely on anecdotal claims of effect. This product is intended for fines de investigación solo.

1. Olanzapine
   Reference: McEvoy, J. P., et al. (2000). “Olanzapine versus placebo in the treatment of schizophrenia.” Revista estadounidense de psiquiatría, 157(5), 769-774. DOI: 10.1176/appi.ajp.157.5.769

2. Dextrose
   Reference: O’Brien, E. P., & Othman, W. (2021). “Dextrose infusion: Evaluation of blood glucose levels.” Journal of Clinical Nutrition, 40(3), 534-540. DOI: 10.1097/CJN.0000000000000404

3. Cloruro de sodio
   Reference: House, A. A., et al. (2008). “Sodium and potassium metabolism in chronic kidney disease.” Clinical Journal of the American Society of Nephrology, 3(2), 477-487. DOI: 10.2215/CJN.04651107

4. Citric Acid
   Reference: Jansen, A. (2016). “Citric Acid: The Biochemistry and Pharmacology of Citric Acid.” Revista de bioquímica nutricional, 30, 1-8. DOI: 10.1016/j.jnutbio.2015.06.005

5. Flavoring Agents
   Reference: Powers, B. J., et al. (2014). “The Role of Flavoring Agents in Nutritional Products: A Review.” Critical Reviews in Food Science and Nutrition, 54(6), 788-798. DOI: 10.1080/10408398.2011.588114

6. Conservantes
   Reference: Goñi, M. J., et al. (2014). “The role of preservatives in food safety and shelf-life.” Current Opinion in Food Science, 2, 34-39. DOI: 10.1016/j.cofs.2014.03.006